Nucana Plc (NCNA) Live Share Price, Invest From India

Nucana Plc Stock Performance

as on March 18, 2026 at 6:53 am IST

Day's High
$1.85
Day's Price Range
$1.96
$1.85
5.95%
Upside
52 Week's Low
52 Week's High
$1.88
52-Week Price Range
$268.00
$1.85
-1.62%
Downside
14386.49%
Upside

Nucana Plc share price movements today

Previous Close: $1.90
Open: $1.88
Volume: 227.2K
Day's Low - High: $1.85 - $1.96
52 Week Low - High: $1.88 - $268.00

Nucana Plc Historical Returns

1 Month Return: -5 %
3 Month Return: -44.61 %
1 Year Return: -98.86 %
3 Year Return: -99.97 %
5 Year Return: -99.99 %

Nucana Plc Stock Fundamentals & Key Indicators

Check Nucana Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.6M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

Industry PE ratio

-4.068794117647059

PEG Ratio

EBITDA

-19.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-181.81%

Nucana Plc Stock Valuation

Track how Nucana Plc P/E has moved over time to understand its valuation trends.

Nucana Plc in the last 5 years

Overview
Trends

Lowest (-174.49x)

December 31, 2021

Industry (-4.07x)

March 17, 2026

Today (0.00x)

March 17, 2026

Highest (-0.07x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.00x

Nucana Plc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nucana Plc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Nucana Plc	BUY	$3.6M	-99.99%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$41.6B	119.71%	135.09	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$119.2B	114.71%	30.68	32.94%
Beone Medicines Ltd	NA	$32.8B	NA	115	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$78.8B	52.6%	17.99	31.41%

Stock Returns calculator for Nucana Plc Stock including INR - Dollar returns

The Nucana Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Nucana Plc investment value today

Current value as on today

₹7,653

Returns

₹92,347

(-92.35%)

Returns from Nucana Plc Stock

₹98,886 (-98.89%)

Dollar Returns*

₹6,539 (+6.54%)

Analyst Recommendation on Nucana Plc Stock

Based on 10 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for Nucana Plc. Average target price of $104

Nucana Plc Share Price Target

Get share price movements and forecasts by analysts on Nucana Plc.

What analysts predicted

98.22%UPSIDE

Target Price

$104

Current Price

$1.85

Analyzed by

10 Analysts

Target

$104.00

Nucana Plc target price $104, a slight upside of 98.22% compared to current price of $1.85. According to 10 analysts rating.

Nucana Plc Stock’s Investor Sentiment and Interest

Search interest for Nucana Plc Stock has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 16, 2026 to March 18, 2026

Change:-40% versus previous 30 day period

Nucana Plc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-6	-8	-9	-8	-8	-5	0	-2	-11	0
EBITDA	-5	-8	-8	-8	-8	-4	-1	-2	-11	-3
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-8	-8	-8	-8	-5	0	-2	-24	0
Income Tax Expense	0	-1	-1	-1	-1	0	0	0	0	0
Net Income	-6	-8	-9	-8	-8	-5	0	-3	-24	0
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Nucana Plc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	0	-	-	-	-	-	-	-
Gross Profit	-	-	0	-	-	-	-	-	-	-
Operating Income	-6	-8	-22	-22	-26	-32	-45	-43	-32	-22
EBITDA	-6	-8	-22	-24	-23	-28	-41	-52	-31	-22
Interest Expense	-	-	-	-	0	6	4	9	1	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-6	-8	-25	-18	-25	-36	-47	-38	-32	-22
Income Tax Expense	-1	-2	-2	-4	-4	-5	-7	-6	-4	-3
Net Income	-7	-7	-30	-17	-28	-41	-53	-38	-34	-24
Net Profit Margin	0.00%	0.00%	-8157.24%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Nucana Plc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-6	-7	-6	-6	-4	0	-2	-24	0
Operating Cash Flow	-10	0	-5	-1	-4	-7	-3	-4	1
Investing Cash Flow	2	0	0	0	0	0	0	0	0
Financing Cash Flow	0	0	1	0	4	2	0	9	15
Change in Cash	-6	0	-4	-1	0	-4	-2	4	16

Nucana Plc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-6	-23	-13	-21	-30	-40	-32	-27	-18
Operating Cash Flow	-9	-8	-12	-23	-21	-23	-23	-26	-19
Investing Cash Flow	14	0	0	0	-1	-3	0	2	0
Financing Cash Flow	0	77	0	0	61	0	0	0	8
Change in Cash	5	66	-9	-25	35	-27	-18	-24	-10

Global Institutional Holdings in Nucana Plc

Funds	Holdings
Global Retirement Partners, LLC.	0%
Susquehanna International Group, LLP	0%
SBI Securities Co Ltd	0%
The Carlyle Group Inc	3.2%
Morgan Stanley - Brokerage Accounts	0%

See all

Insights on Nucana Plc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 72.0% return, outperforming this stock by 172.0%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 26.0% return, outperforming this stock by 124.9%
NEGATIVE IMPACT
Price Dip
In the last 3 months, NCNA stock has moved down by -44.6%

About Nucana Plc

nucana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our phosphoramidate chemistry technology to transform some of the most widely prescribed chemotherapy agents into more effective and safer medicines. while these conventional agents remain part of the standard of care for the treatment of many solid tumours, their efficacy is limited by cancer cell resistance mechanisms and they are often poorly tolerated. utilising our proprietary protide technology, we are developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells.

Organisation	Nucana Plc
Headquarters	3 Lochside Way, Edinburgh, United Kingdom, EH12 9DT
Industry	Health Technology
CEO	Mr. Hugh Stephen Griffith
E-voting on shares	Click here to vote

Key Management of Nucana Plc

Name	Title
Mr. Martin Alexander Quinn	Company Secretary
Prof. David Harrison	Head of Translational Medicine & Studies
Ms. Theresa Bruce	Chief Operating Officer
Mr. Gordon Kennovin	Senior VP of CMC & Development
Mr. Ian Webster	Interim Chief Financial Officer
Dr. Stuart Grant	Senior Vice President of Regulatory Affairs
Mr. Andrew Martin Kay B. Pharm	Independent Executive Chairman of the Board
Mr. Hugh Stephen Griffith	Founder, CEO & Executive Director
Dr. Jeffrey D. Bloss F.A.C.O.G., M.D.	Chief Medical Officer

FAQs

What is Nucana Plc share price today?

Nucana Plc share price today is $1.85 as on March 18, 2026 at 1:23 am IST at the close of the market. Nucana Plc share today touched a day high of $1.96 and a low of $1.85.

What is the 52 week high and 52 week low for Nucana Plc share?

Nucana Plc share touched a 52 week high of $268 on March 28, 2025 and a 52 week low of $1.88 on March 16, 2026. Nucana Plc stock price today i.e. March 18, 2026 at 1:23 am IST is closed at $1.85,which is 99.31% down from its 52 week high and -1.60% up from its 52 week low.

What is Nucana Plc's market capitalisation today?

Nucana Plc market capitalisation is $0.00T as on March 18, 2026 at 1:23 am IST.

How to invest in Nucana Plc Stock (NCNA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Nucana Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nucana Plc Shares that will get you 0.8108 shares as per Nucana Plc share price of $1.85 per share as on March 18, 2026 at 1:23 am IST.

What is the minimum amount required to buy Nucana Plc Stock (NCNA) from India?

Indian investors can start investing in Nucana Plc (NCNA) shares with as little as ₹92.369 or $1 (as of March 18, 2026 at 5:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹923.69 in Nucana Plc stock (as per the Rupee-Dollar exchange rate as on March 18, 2026 at 5:39 am IST). Based on Nucana Plc share’s latest price of $1.85 as on March 18, 2026 at 1:23 am IST, you will get 5.4054 shares of Nucana Plc. Learn more about fractional shares .

What are the returns that Nucana Plc has given to Indian investors in the last 5 years?

Nucana Plc stock has given -99.99% share price returns and 27.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?